HVAC
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Huntington's Disease Therapeutics Market Research Report 2023
1 Huntington's Disease Therapeutics Market Overview
1.1 Product Overview and Scope of Huntington's Disease Therapeutics
1.2 Huntington's Disease Therapeutics Segment by Type
1.2.1 Global Huntington's Disease Therapeutics Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Antidopaminergics
1.2.3 Anticonvulsants
1.2.4 Antipsychotics
1.2.5 Antidepressants
1.3 Huntington's Disease Therapeutics Segment by Application
1.3.1 Global Huntington's Disease Therapeutics Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.4 Global Huntington's Disease Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Huntington's Disease Therapeutics Revenue 2017-2028
1.4.2 Global Huntington's Disease Therapeutics Sales 2017-2028
1.4.3 Huntington's Disease Therapeutics Market Size by Region: 2017 Versus 2021 Versus 2028
2 Huntington's Disease Therapeutics Market Competition by Manufacturers
2.1 Global Huntington's Disease Therapeutics Sales Market Share by Manufacturers (2017-2022)
2.2 Global Huntington's Disease Therapeutics Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Huntington's Disease Therapeutics Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Huntington's Disease Therapeutics Manufacturing Sites, Area Served, Product Type
2.5 Huntington's Disease Therapeutics Market Competitive Situation and Trends
2.5.1 Huntington's Disease Therapeutics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Huntington's Disease Therapeutics Players Market Share by Revenue
2.5.3 Global Huntington's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Huntington's Disease Therapeutics Retrospective Market Scenario by Region
3.1 Global Huntington's Disease Therapeutics Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Huntington's Disease Therapeutics Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Huntington's Disease Therapeutics Market Facts & Figures by Country
3.3.1 North America Huntington's Disease Therapeutics Sales by Country
3.3.2 North America Huntington's Disease Therapeutics Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Huntington's Disease Therapeutics Market Facts & Figures by Country
3.4.1 Europe Huntington's Disease Therapeutics Sales by Country
3.4.2 Europe Huntington's Disease Therapeutics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Huntington's Disease Therapeutics Market Facts & Figures by Region
3.5.1 Asia Pacific Huntington's Disease Therapeutics Sales by Region
3.5.2 Asia Pacific Huntington's Disease Therapeutics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Huntington's Disease Therapeutics Market Facts & Figures by Country
3.6.1 Latin America Huntington's Disease Therapeutics Sales by Country
3.6.2 Latin America Huntington's Disease Therapeutics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Huntington's Disease Therapeutics Market Facts & Figures by Country
3.7.1 Middle East and Africa Huntington's Disease Therapeutics Sales by Country
3.7.2 Middle East and Africa Huntington's Disease Therapeutics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Huntington's Disease Therapeutics Historic Market Analysis by Type
4.1 Global Huntington's Disease Therapeutics Sales Market Share by Type (2017-2022)
4.2 Global Huntington's Disease Therapeutics Revenue Market Share by Type (2017-2022)
4.3 Global Huntington's Disease Therapeutics Price by Type (2017-2022)
5 Global Huntington's Disease Therapeutics Historic Market Analysis by Application
5.1 Global Huntington's Disease Therapeutics Sales Market Share by Application (2017-2022)
5.2 Global Huntington's Disease Therapeutics Revenue Market Share by Application (2017-2022)
5.3 Global Huntington's Disease Therapeutics Price by Application (2017-2022)
6 Key Companies Profiled
6.1 F. Hoffmann-La Roche
6.1.1 F. Hoffmann-La Roche Corporation Information
6.1.2 F. Hoffmann-La Roche Description and Business Overview
6.1.3 F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2017-2022)
6.1.4 F. Hoffmann-La Roche Huntington's Disease Therapeutics Product Portfolio
6.1.5 F. Hoffmann-La Roche Recent Developments/Updates
6.2 H. Lundbeck
6.2.1 H. Lundbeck Corporation Information
6.2.2 H. Lundbeck Description and Business Overview
6.2.3 H. Lundbeck Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2017-2022)
6.2.4 H. Lundbeck Huntington's Disease Therapeutics Product Portfolio
6.2.5 H. Lundbeck Recent Developments/Updates
6.3 Prana Biotechnology
6.3.1 Prana Biotechnology Corporation Information
6.3.2 Prana Biotechnology Description and Business Overview
6.3.3 Prana Biotechnology Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Prana Biotechnology Huntington's Disease Therapeutics Product Portfolio
6.3.5 Prana Biotechnology Recent Developments/Updates
6.4 Teva Pharmaceutical Industries
6.4.1 Teva Pharmaceutical Industries Corporation Information
6.4.2 Teva Pharmaceutical Industries Description and Business Overview
6.4.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Product Portfolio
6.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.5 Horizon Pharma
6.5.1 Horizon Pharma Corporation Information
6.5.2 Horizon Pharma Description and Business Overview
6.5.3 Horizon Pharma Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Horizon Pharma Huntington's Disease Therapeutics Product Portfolio
6.5.5 Horizon Pharma Recent Developments/Updates
7 Huntington's Disease Therapeutics Manufacturing Cost Analysis
7.1 Huntington's Disease Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Huntington's Disease Therapeutics
7.4 Huntington's Disease Therapeutics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Huntington's Disease Therapeutics Distributors List
8.3 Huntington's Disease Therapeutics Customers
9 Huntington's Disease Therapeutics Market Dynamics
9.1 Huntington's Disease Therapeutics Industry Trends
9.2 Huntington's Disease Therapeutics Market Drivers
9.3 Huntington's Disease Therapeutics Market Challenges
9.4 Huntington's Disease Therapeutics Market Restraints
10 Global Market Forecast
10.1 Huntington's Disease Therapeutics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Huntington's Disease Therapeutics by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Huntington's Disease Therapeutics by Type (2023-2028)
10.2 Huntington's Disease Therapeutics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Huntington's Disease Therapeutics by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Huntington's Disease Therapeutics by Application (2023-2028)
10.3 Huntington's Disease Therapeutics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Huntington's Disease Therapeutics by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Huntington's Disease Therapeutics by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Huntington's Disease Therapeutics Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Huntington's Disease Therapeutics Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Huntington's Disease Therapeutics Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Huntington's Disease Therapeutics Market Competitive Situation by Manufacturers in 2021
Table 5. Global Huntington's Disease Therapeutics Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Huntington's Disease Therapeutics Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Huntington's Disease Therapeutics Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Huntington's Disease Therapeutics Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Huntington's Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Huntington's Disease Therapeutics Manufacturing Sites and Area Served
Table 11. Manufacturers Huntington's Disease Therapeutics Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Huntington's Disease Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Huntington's Disease Therapeutics as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Huntington's Disease Therapeutics Sales by Region (2017-2022) & (K Units)
Table 16. Global Huntington's Disease Therapeutics Sales Market Share by Region (2017-2022)
Table 17. Global Huntington's Disease Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Huntington's Disease Therapeutics Revenue Market Share by Region (2017-2022)
Table 19. North America Huntington's Disease Therapeutics Sales by Country (2017-2022) & (K Units)
Table 20. North America Huntington's Disease Therapeutics Sales Market Share by Country (2017-2022)
Table 21. North America Huntington's Disease Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Huntington's Disease Therapeutics Revenue Market Share by Country (2017-2022)
Table 23. Europe Huntington's Disease Therapeutics Sales by Country (2017-2022) & (K Units)
Table 24. Europe Huntington's Disease Therapeutics Sales Market Share by Country (2017-2022)
Table 25. Europe Huntington's Disease Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Huntington's Disease Therapeutics Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Huntington's Disease Therapeutics Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Huntington's Disease Therapeutics Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Huntington's Disease Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Huntington's Disease Therapeutics Revenue Market Share by Region (2017-2022)
Table 31. Latin America Huntington's Disease Therapeutics Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Huntington's Disease Therapeutics Sales Market Share by Country (2017-2022)
Table 33. Latin America Huntington's Disease Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Huntington's Disease Therapeutics Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Huntington's Disease Therapeutics Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Huntington's Disease Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Huntington's Disease Therapeutics Revenue Market Share by Country (2017-2022)
Table 39. Global Huntington's Disease Therapeutics Sales by Type (2017-2022) & (K Units)
Table 40. Global Huntington's Disease Therapeutics Sales Market Share by Type (2017-2022)
Table 41. Global Huntington's Disease Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Huntington's Disease Therapeutics Revenue Share by Type (2017-2022)
Table 43. Global Huntington's Disease Therapeutics Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Huntington's Disease Therapeutics Sales (K Units) by Application (2017-2022)
Table 45. Global Huntington's Disease Therapeutics Sales Market Share by Application (2017-2022)
Table 46. Global Huntington's Disease Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Huntington's Disease Therapeutics Revenue Share by Application (2017-2022)
Table 48. Global Huntington's Disease Therapeutics Price by Application (2017-2022) & (USD/Unit)
Table 49. F. Hoffmann-La Roche Corporation Information
Table 50. F. Hoffmann-La Roche Description and Business Overview
Table 51. F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. F. Hoffmann-La Roche Huntington's Disease Therapeutics Product
Table 53. F. Hoffmann-La Roche Recent Developments/Updates
Table 54. H. Lundbeck Corporation Information
Table 55. H. Lundbeck Description and Business Overview
Table 56. H. Lundbeck Huntington's Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. H. Lundbeck Huntington's Disease Therapeutics Product
Table 58. H. Lundbeck Recent Developments/Updates
Table 59. Prana Biotechnology Corporation Information
Table 60. Prana Biotechnology Description and Business Overview
Table 61. Prana Biotechnology Huntington's Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Prana Biotechnology Huntington's Disease Therapeutics Product
Table 63. Prana Biotechnology Recent Developments/Updates
Table 64. Teva Pharmaceutical Industries Corporation Information
Table 65. Teva Pharmaceutical Industries Description and Business Overview
Table 66. Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Teva Pharmaceutical Industries Huntington's Disease Therapeutics Product
Table 68. Teva Pharmaceutical Industries Recent Developments/Updates
Table 69. Horizon Pharma Corporation Information
Table 70. Horizon Pharma Description and Business Overview
Table 71. Horizon Pharma Huntington's Disease Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Horizon Pharma Huntington's Disease Therapeutics Product
Table 73. Horizon Pharma Recent Developments/Updates
Table 74. Production Base and Market Concentration Rate of Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Huntington's Disease Therapeutics Distributors List
Table 77. Huntington's Disease Therapeutics Customers List
Table 78. Huntington's Disease Therapeutics Market Trends
Table 79. Huntington's Disease Therapeutics Market Drivers
Table 80. Huntington's Disease Therapeutics Market Challenges
Table 81. Huntington's Disease Therapeutics Market Restraints
Table 82. Global Huntington's Disease Therapeutics Sales Forecast by Type (2023-2028) & (K Units)
Table 83. Global Huntington's Disease Therapeutics Sales Market Share Forecast by Type (2023-2028)
Table 84. Global Huntington's Disease Therapeutics Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 85. Global Huntington's Disease Therapeutics Revenue Market Share Forecast by Type (2023-2028)
Table 86. Global Huntington's Disease Therapeutics Sales Forecast by Application (2023-2028) & (K Units)
Table 87. Global Huntington's Disease Therapeutics Sales Market Share Forecast by Application (2023-2028)
Table 88. Global Huntington's Disease Therapeutics Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 89. Global Huntington's Disease Therapeutics Revenue Market Share Forecast by Application (2023-2028)
Table 90. Global Huntington's Disease Therapeutics Sales Forecast by Region (2023-2028) & (K Units)
Table 91. Global Huntington's Disease Therapeutics Sales Market Share Forecast by Region (2023-2028)
Table 92. Global Huntington's Disease Therapeutics Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 93. Global Huntington's Disease Therapeutics Revenue Market Share Forecast by Region (2023-2028)
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Huntington's Disease Therapeutics
Figure 2. Global Huntington's Disease Therapeutics Market Share by Type in 2021 & 2028
Figure 3. Antidopaminergics Product Picture
Figure 4. Anticonvulsants Product Picture
Figure 5. Antipsychotics Product Picture
Figure 6. Antidepressants Product Picture
Figure 7. Global Huntington's Disease Therapeutics Market Share by Application in 2021 & 2028
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Diagnostic Centers
Figure 11. Global Huntington's Disease Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Huntington's Disease Therapeutics Market Size (2017-2028) & (US$ Million)
Figure 13. Global Huntington's Disease Therapeutics Sales (2017-2028) & (K Units)
Figure 14. Huntington's Disease Therapeutics Sales Share by Manufacturers in 2021
Figure 15. Global Huntington's Disease Therapeutics Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Huntington's Disease Therapeutics Players: Market Share by Revenue in 2021
Figure 17. Huntington's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Huntington's Disease Therapeutics Sales Market Share by Region (2017-2022)
Figure 19. Global Huntington's Disease Therapeutics Sales Market Share by Region in 2021
Figure 20. Global Huntington's Disease Therapeutics Revenue Market Share by Region (2017-2022)
Figure 21. Global Huntington's Disease Therapeutics Revenue Market Share by Region in 2021
Figure 22. U.S. Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Taiwan Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Philippines Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Vietnam Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. U.A.E Huntington's Disease Therapeutics Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Huntington's Disease Therapeutics by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Huntington's Disease Therapeutics
Figure 48. Manufacturing Process Analysis of Huntington's Disease Therapeutics
Figure 49. Huntington's Disease Therapeutics Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
F. Hoffmann-La Roche H. Lundbeck Prana Biotechnology Teva Pharmaceutical Industries Horizon Pharma